Cite
APA Citation
Francois, B., Lambden, S., Gibot, S., Derive, M., Olivier, A., Cuvier, V., Witte, S., Grouin, J., Garaud, J. J., Salcedo-Magguilli, M., Levy, M., & Laterre, P. (2021). rationale and protocol for the efficacy, safety and tolerability of nangibotide in patients with septic shock (ASTONISH) phase IIb randomised controlled trial. BMJ open, 11(7), . http://access.bl.uk/ark:/81055/vdc_100133936679.0x000030